Micronics Awarded 2 Microfluidics Patents
Micronics Inc. of Redmond, Wash., a developer of molecular and immunohematology diagnostic tests, announced today that it has been issued two patents from the US Patent and Trademark Office for novel microfluidic devices and methods relating to the company’s focus on developing rapid and easy-to-use clinical diagnostic products. Using microfluidics, the company substantially reduces the volumes of sample and reagents required to produce a test result, generally within a fraction of the time and cost that traditional reference lab and benchtop methods require. The first patent (No. 7,416,892) has broad applicability for molecular diagnostics; it identifies an integrated microfluidic system for isolating, amplifying, and detecting DNA or RNA from biological fluids, with all processing steps done within the microfluidic lab-on-a-card format. The second patent (No. 7,419,638) relates primarily to microfluidic systems for detecting a person’s blood type and Rh status in a sanitary, disposable, credit card-sized device. In addition, the patent is directed to the placement of dried biological agents and liquid buffers into the microfluidic device, which results in a closed system that permits multiple assay steps to be processed without additional human interaction.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024